Lipocine
LPCN
LPCN
45 hedge funds and large institutions have $21.9M invested in Lipocine in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 18 closing their positions.
Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
12
Reduced
14
Closed
18
Calls
$1.4M
Puts
$801K
Net Calls
+$594K
Net Calls Change
+$477K
Top Buyers
| 1 |
DAM
1
DLD Asset Management
New York
|
$730K |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.2M |
| 3 |
3
Millennium Management
New York
|
$769K |
| 4 |
ECM
4
Element Capital Management
New York
|
$325K |
| 5 |
5
Goldman Sachs
New York
|
$300K |
Top Sellers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$0 |
| 2 |
2
BlackRock
New York
|
$1.17M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$63K |
| 4 |
4
JPMorgan Chase & Co
New York
|
$0 |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$123K |
